THE EFFECTIVENESS AND TOLERABILITY OF COMBINED TREATMENT WITH PEGINTERFERON ALPHA-2A OR ALPHA-2B AND RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C: RESULTS BASED ON THE NATIONWIDE HEPATITIS REGISTRY IN JAPAN

被引：0
|
作者：
Shimbo, T. [1 ]
Miyaki, K. [1 ]
Song, Y. [1 ]
Masaki, N. [1 ]
机构：
[1] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.750
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A326 / A326
页数：1
相关论文
共 50 条
  • [41] Peg interferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive patients in Egypt
    Elwaki, M. R.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    El-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    LIVER INTERNATIONAL, 2006, 26 : 84 - 84
  • [42] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [43] Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon alpha-2a and Ribavirin for Chronic Hepatitis C
    Rathi, Chetan
    Pipaliya, Nirav
    Choksi, Dhaval
    Parikh, Pathik
    Ingle, Meghraj
    Sawant, Prabha
    ACG CASE REPORTS JOURNAL, 2015, 2 (04): : 247 - 249
  • [44] Peginterferon ALPHA-2A (40KD) Plus Ribavirin for the Treatment of Patients With Chronic Hepatitis C (CHC) and Compensated Liver Cirrhosis in Japan
    Izumi, Namiki
    Kaneko, Shuichi
    Nishiguchi, Shuhei
    Kudo, Masatoshi
    Sata, Michio
    Omata, Masao
    GASTROENTEROLOGY, 2011, 140 (05) : S950 - S950
  • [45] Facial Hyperpigmentation in association with peginterferon alpha-2a and ribavirin treatment for chronic hepatitis C patient: A case report
    Singh, Mandeep
    Sheikh, Muhammad Y.
    Singh, Jasjit
    Sanousi, Nazar E.
    Garcia, Sonia
    Futoran, Robert
    Bashir, Muhammad H.
    Shah, Kandarp K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S338 - S338
  • [46] Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a
    Marcellin, Patrick
    Lau, George K. K.
    Zeuzem, Stefan
    Heathcote, E. Jenny
    Pockros, Paul J.
    Reddy, K. Rajender
    Piratvisuth, Teerha
    Farci, Patrizia
    Chow, Wan-Cheng
    Jia, Ji-Dong
    Paik, Woon
    Wintfeld, Neil
    Pluck, Nigel
    LIVER INTERNATIONAL, 2008, 28 (04) : 477 - 485
  • [47] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [48] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [49] Combined treatment with interferon alpha-2b and cyclosporin A for chronic hepatitis C.
    Inoue, K
    Yoshiba, M
    HEPATOLOGY, 1997, 26 (04) : 1886 - 1886
  • [50] COST-EFFECTIVENESS ANALYSIS OF PEGYLATED INTERFERON ALPHA-2A VERSUS PEGYLATED INTERFERON ALPHA-2B IN THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN POLAND
    Macioch, T.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A274 - A275
12345